What is Opus Genetics's change in accrued liabilities?

Opus Genetics (IRD) reported change in accrued liabilities of $432K in Q1 2026.

How has Opus Genetics's change in accrued liabilities changed year-over-year?

Opus Genetics's change in accrued liabilities increased by 58.8% year-over-year, from $272K to $432K.

What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

Opus Genetics IRD Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

MeiraGTx Holdings plcMGTX

-$9.9M-176%

4D Molecular TherapeuticsFDMT

-$4.12M-78.3%

Opko HealthOPK

-$8.16M+57.9%

Kodiak Sciences IncKOD

$4.56M+93.5%

RegenxbioRGNX

-$16.73M-15.5%

Prime MedicinePRME

-$4.5M+32.4%

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's change in accrued liabilities?: Opus Genetics (IRD) reported change in accrued liabilities of $432K in Q1 2026.
How has Opus Genetics's change in accrued liabilities changed year-over-year?: Opus Genetics's change in accrued liabilities increased by 58.8% year-over-year, from $272K to $432K.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.